11 – 20 of 74
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype
- Contribution to journal › Article
-
Mark
Desmoglein-2 is important for islet function and β-cell survival
- Contribution to journal › Article
-
Mark
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
- Contribution to journal › Article
-
Mark
B Cells and Tertiary Lymphoid Structures : Friends or Foes in Cancer Immunotherapy?
- Contribution to journal › Scientific review
- 2021
-
Mark
A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis
- Contribution to journal › Article
-
Mark
Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens
- Contribution to journal › Article
-
Mark
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma
- Contribution to journal › Article
-
Mark
BRN2 is a non-canonical melanoma tumor-suppressor
- Contribution to journal › Article
-
Mark
Pan-cancer application of a lung-adenocarcinoma-derived gene-expression-based prognostic predictor
- Contribution to journal › Article
-
Mark
Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
- Contribution to journal › Article
